Elite Pharmaceuticals Inc (ELTP)
0.1298
0.00 (0.00%)
USD |
OTCM |
May 03, 14:35
Elite Pharmaceuticals Max Drawdown (5Y): 89.83% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 89.83% |
| March 31, 2024 | 90.10% |
| February 29, 2024 | 90.10% |
| January 31, 2024 | 90.10% |
| December 31, 2023 | 90.10% |
| November 30, 2023 | 90.10% |
| October 31, 2023 | 90.50% |
| September 30, 2023 | 92.16% |
| August 31, 2023 | 92.16% |
| July 31, 2023 | 92.16% |
| June 30, 2023 | 92.16% |
| May 31, 2023 | 92.16% |
| April 30, 2023 | 92.16% |
| March 31, 2023 | 92.16% |
| February 28, 2023 | 92.16% |
| January 31, 2023 | 92.16% |
| December 31, 2022 | 92.16% |
| November 30, 2022 | 92.16% |
| October 31, 2022 | 92.16% |
| September 30, 2022 | 92.16% |
| August 31, 2022 | 92.16% |
| July 31, 2022 | 92.16% |
| June 30, 2022 | 92.16% |
| May 31, 2022 | 92.16% |
| April 30, 2022 | 92.16% |
| Date | Value |
|---|---|
| March 31, 2022 | 92.16% |
| February 28, 2022 | 92.16% |
| January 31, 2022 | 92.16% |
| December 31, 2021 | 92.16% |
| November 30, 2021 | 92.16% |
| October 31, 2021 | 92.16% |
| September 30, 2021 | 92.16% |
| August 31, 2021 | 92.16% |
| July 31, 2021 | 92.16% |
| June 30, 2021 | 92.16% |
| May 31, 2021 | 92.16% |
| April 30, 2021 | 92.16% |
| March 31, 2021 | 92.16% |
| February 28, 2021 | 92.16% |
| January 31, 2021 | 92.16% |
| December 31, 2020 | 92.16% |
| November 30, 2020 | 92.16% |
| October 31, 2020 | 92.16% |
| September 30, 2020 | 92.16% |
| August 31, 2020 | 92.16% |
| July 31, 2020 | 92.16% |
| June 30, 2020 | 92.16% |
| May 31, 2020 | 92.16% |
| April 30, 2020 | 92.16% |
| March 31, 2020 | 92.16% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
89.83%
Minimum
Apr 2024
92.16%
Maximum
May 2019
91.92%
Average
92.16%
Median
May 2019
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 6.182 |
| Beta (5Y) | -0.0818 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 78.15% |
| Historical Sharpe Ratio (5Y) | 0.0674 |
| Historical Sortino (5Y) | 0.2082 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.53% |